SPINOVIT
Spinovit, a UCLouvain spin-off, is developing a method for the quantitative analysis of an oxygen-sensitive blood biomarker to measure endothelial dysfunction and prevent risks.
Similar Organizations
DentComp
DentComp provides a tool for early detection of diseases and creates effective tailored chemical treatments within the oral cavity
Galleria Eyecare
Galleria Eyecare is to provide exemplary eye care for the whole family is one of a kind service and selection with a friendly.
Medivalve
MediValve is developing a new, innovative medical device intended to facilitate the accurate placement and alignment of medical devices
RSV NewCo
RSV NewCo is developing a safe, effective treatment for Respiratory Syncytial Virus.
Somnolytics
Somnolytics is a company that seeks to provide Flumazenil to patients with the primary hypersomnias.
US Biometrix
US Biometrix is transforming behavioral health by creating objective quantifiable measurements and their measuring their changes
Viasonix
Viasonix is a medical device company that develops and designs a wide range of advanced vascular medical devices.
Investors List
Vives Louvain Technology Fund
Vives Louvain Technology Fund investment in Seed Round - Spinovit
More informations about "Spinovit"
Preventing the cardiovascular diseases | Spinovit | Belgium
Spinovit ended its activity in September 2023. For any enquiry, please contact the former CEO at: [email protected]. Any correspondence can be addressed to: VanOver. 32, chemin des …See details»
Spinovit Company Profile 2024: Valuation, Funding & Investors
Spinovit General Information Description. Provider of diagnostic services intended to detect the earliest stages of cardiovascular disease. The company uses electron paramagnetic …See details»
Spinovit | VIVES fund
Spinovit, a UCLouvain spin-off, is developing a method for the quantitative analysis of an oxygen-sensitive blood biomarker to measure endothelial dysfunction and prevent cardiovascular …See details»
SPINOVIT - LinkedIn
SPINOVIT is a spin off from UCLouvain offering a solution to detect the earliest stages of a cardiovascular disease. The assessment of a robust biomarker of endothelial dysfunction …See details»
Spinovit SRL - Drug pipelines, Patents, Clinical trials - Synapse
Explore Spinovit SRL with its drug pipeline, therapeutic area, technology platform, 1 clinical trial.See details»
Picking up early signals: SPINOVIT to prevent …
Oct 19, 2022 According to the World Health Organization (WHO), around 18 million people died from such illnesses in 2019, with heart attack and stroke being the most common culprits. “About 8 out of 10 of these cardiovascular deaths …See details»
Spinovit - Funding, Financials, Valuation & Investors - Crunchbase
Jan 1, 2022 Spinovit is developing a method for the quantitative analysis of an oxygen-sensitive blood biomarker to measure endothelial dysfunction. Search Crunchbase. ... How much …See details»
SPINOVIT Overview | SignalHire Company Profile
SPINOVIT is a spin off from UCLouvain offering a solution to detect the earliest stages of a cardiovascular disease. The assessment of a robust biomarker of endothelial dysfunction …See details»
Our mission - SPINOVIT
Cardiovascular diseases are the first cause of mortality in Western countries and are estimated to cause 31% of all deaths worldwide (WHO statistics, January 2015).See details»
Spinovit - Overview, News & Similar companies | ZoomInfo.com
SPINOVIT is a spin-off from UCL funded by the Walloon Region. Read More. Spinovit's Social Media. Is this data correct? Popular Searches Spinovit SIC Code 72,722 NAICS Code 54,541 …See details»
Prevent cardiovascular diseases thanks to a blood test
Nov 29, 2022 Spinovit has just raised a seed round of 535,000 € and has received a repayable advance of 470,000 € from Wallonia to demonstrate the predictability of its cardiovascular …See details»
Spinovit - Facebook
Spinovit. 81 likes. SPINOVIT aims at preventing people developing a cardiovascular disease. We provide a solution allowing to assess the health of your...See details»
Spinovit - Updates, News, Events, Signals & Triggers - Crunchbase
Spinovit is developing a method for the quantitative analysis of an oxygen-sensitive blood biomarker to measure endothelial dysfunction. Search Crunchbase. Start Free Trial . Chrome …See details»
You as a patient | SPINOVIT
Presently, in order to prevent a cardiovascular disease, physicians record the risk factors (BMI, smoking, blood pressure, cholesterol, glycemia, age and gender) of the patient.See details»
Spinovit - Crunchbase
Organization. Spinovit . Connect to CRM . Save . Summary Financials People Signals & News Similar Companies. Similar Companies. Edit Similar Companies Section. Companies like …See details»
The Art of Corporate Spin-Outs: When to spin-out? How to
Nov 14, 2023 This new entity, the spin-out, usually originates from the research or innovations developed within the parent organization. The purpose of a spin-out is to commercialize these …See details»
Foremost Clean Energy Announces Approval of the Winston Gold …
6 hours ago Immediately prior to the closing (the “Effective Date”), all Foremost shareholders are expected to receive two shares of Rio Grande for every one share of Foremost they hold …See details»
Seed Round - Spinovit - 2022-01-01 - Crunchbase
Jan 1, 2022 Organization Name . Spinovit . Announced Date Jan 1, 2022; Funding Type Seed; Funding Stage Seed; Investors. Edit Investors Section. Number of Investors 1. Investor Name …See details»
Our technology | SPINOVIT
A key mediator of endothelial protective effects is nitric oxide, produced by the endothelial nitric oxide synthase. In a previous Wallonia-funded research programme, we have quantified by …See details»
2024-12-23 | Foremost Clean Energy Announces Approval of
6 hours ago (a) setting the size of the Company’s board of directors (the “Board”) at six (6), and electing the following individuals as directors …See details»